subject area of
- Benralizumab attenuates airway eosinophilia in prednisone-dependent asthma Academic Article
- Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study Academic Article
- Cord blood molecular biomarkers of eosinophilopoiesis: Kinetic analysis of GATA-1, MBP1 and IL-5Rα mRNA expression Academic Article
- IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis Academic Article
- Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice Academic Article
- MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function Academic Article
- Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma Academic Article
- Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma Academic Article